Skip to content

Study to assess efficacy of Malatidalarasa Pichuvarti against Thindukadi pichuvarti in CSOM

Efficacy of Malati dalarasa pichuvarti against Thindukadi pichuvarti in Chronic Suppurative Otitis Media A non randomized controlled trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/105509
Enrollment
42
Registered
2026-03-06
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H65-H75- Diseases of middle ear and mastoid

Interventions

None listed

Sponsors

Government Ayurveda College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Research participants in the age group of 12 to 60 years who met the diagnostic criteria.Participants who will provide informed consent. According to Open access guide to Audiology and Hearing aids for Otolaryngologist Impaired or absent mobility on Pneumatic otoscopy Type C retraction or Type B perforation of tympanic membrane on Tympanogram A Grade 6 score on the OM scale Indicates a tympanic membrane with chronic perforation and recurrent secretion or pus. These findings confirm a diagnosis of Chronic Suppurative Otitis Media

Exclusion criteria

Exclusion criteria: Participants having uncontrolled Diabetes Hypertension and known case of Malignancy. Those who are on steroids for other illness. Who had undergone any previous ear surgery. Pregnant and lactating women. Who are having bloodstained aural discharge Cholesteatoma Mastoiditis Mastoid Fistula.

Design outcomes

Primary

MeasureTime frame
primary outcome : To compare the efficacy of Malati dalarasa pichuvarti against Thindukadi pichu varti when used along with conventional ayurvedic treatments in Chronic Suppurative Otitis MediaTimepoint: Changes in subjective (aural discharge, fullness, itching) and objective (discharge) parameters in the affected ear is taken as primary outcome which will be assessment on 0th day, 1st day, 7th day, 15th day and follow up after 1 month (46th day).

Secondary

MeasureTime frame
Quality of life of patient assessed using COMOT 15 tool.Timepoint: 0th day & after 1 month (46th day)

Countries

India

Contacts

Public ContactArunima Krishnan R

Government Ayurveda College Thiruvananthapuram

arunimaradhakrishnan1997@gmail.com8891976812

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026